Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study-Reference-Cited by-同舟云学术

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Honda Takanori¹,Chen Sanmei¹,Hata Jun¹²³,Yoshida Daigo¹,Hirakawa Yoichiro¹³,Furuta Yoshihiko¹³⁴,Shibata Mao¹²,Sakata Satoko¹²³,Kitazono Takanari²³,Ninomiya Toshiharu¹²

Affiliation:

1. Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University

2. Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University

3. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

4. Department of Medical-Engineering Collaboration for Healthy Longevity, Graduate School of Medical Sciences, Kyushu University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_61960/_pdf

Reference32 articles.

1. 1) Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J, 2004; 25: 1197-1207

2. 2) Hoshino T, Sissani L, Labreuche J, Ducrocq G, Lavallée PC, Meseguer E, Guidoux C, Cabrejo L, Hobeanu C, Gongora-Rivera F, Touboul PJ, Gabriel Steg P, Amarenco P. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol, 2018; 75: 203-211

3. 3) Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb, 2015; 22: 1287-1304

4. 4) Bhatt DL, Gabriel Steg P, Magnus Ohman E, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PWF. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 2006; 295: 180-189

5. 5) Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, Van Der Schouw YT, Peelen LM, Moons KGM. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ, 2016; 353: i2416

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between time to treatment and outcome in branch retinal vein occlusion;International Ophthalmology;2024-08-25

2. Health guidance intervention mitigates the escalation of predicted comprehensive cardiovascular disease risk: Interrupted time series design;Preventive Medicine;2024-06

3. Association between atherosclerotic cardiovascular disease score and skin carotenoid levels estimated via refraction spectroscopy in the Japanese population: a cross-sectional study;Scientific Reports;2024-05-28

4. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease;Cardiovascular Diabetology;2024-05-10

5. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease;Circulation Journal;2024-04-25